Morton Community Bank’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.95M Buy
+26,094
New +$4.91M 1.01% 37
2026
Q1
Sell
-25,489
Closed -$4.73M 116
2025
Q4
$4.73M Buy
25,489
+849
+3% +$149K 1.02% 37
2025
Q3
$4.06M Buy
24,640
+1,265
+5% +$191K 0.94% 46
2025
Q2
$3.27M Buy
23,375
+1,140
+5% +$160K 0.81% 71
2025
Q1
$3.27M Buy
22,235
+1,072
+5% +$155K 0.86% 67
2024
Q4
$2.77M Buy
21,163
+1,203
+6% +$168K 0.73% 78
2024
Q3
$3.11M Buy
19,960
+402
+2% +$64.9K 0.81% 76
2024
Q2
$3.05M Buy
19,558
+3,285
+20% +$494K 0.86% 63
2024
Q1
$2.2M Buy
+16,273
New +$2.15M 0.63% 87

Other funds holding AZN

Morton Community Bank's AZN Position: Q2 2026 in Review

Morton Community Bank opened a new position in AstraZeneca (AZN) in Q2 2026: 26,094 shares worth $4.95M. The stake represents 1.01% of the portfolio and ranks #37 among its holdings. This is a return to the name: Morton Community Bank previously reported a position in AZN as recently as Q4 2025.

Morton Community Bank first reported a position in AZN in Q1 2024 and has held it in 9 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Morton Community Bank held 26,094 shares of AstraZeneca worth $4.95M as of Q2 2026.
  • AstraZeneca was a new Morton Community Bank position in Q2 2026.
  • AstraZeneca made up 1.01% of Morton Community Bank's portfolio in Q2 2026, its #37 holding.
  • Morton Community Bank first reported a position in AstraZeneca in Q1 2024 and has held it in 9 quarters since.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Morton Community Bank's 13F filing for Q2 2026, filed 14 Aug 2026.